HIMSSCast: The future of telehealth reimbursement

Limits and uncertainty close to telehealth reimbursement have generally been an impediment to adoption. During the COVID-19 crisis, that stress was eased considerably, but now the new ordinary is beginning to acquire condition. What limitations nonetheless stay to telehealth reimbursement, and how may they be conquer? To reply that issue, host Jonah Comstock and Health care Finance News Taking care of Editor Susan Morse welcome McKinsey & Firm partners Oleg Bestsennyy and Gunjan Khanna.

This episode is brought to you by BlueJeans.

Like what you listen to? Subscribe to the podcast on Apple Podcasts, Spotify or Google Enjoy!


Speaking points:

  • COVID-19 reimbursement improvements and which of them will stick close to
  • Adoption lessons realized and how they’ll impact reimbursement coverage
  • Holistic tele-care and care further than the online video visit
  • Impact of new entrants and innovation on the place
  • Is payment-for-services reimbursement an innovation blocker?
  • Reimbursement for different telehealth modalities
  • Time to lead rather than follow for non-public payers?
  • The nonetheless-unresolved issue of induced utilization
  • The rise of worth-dependent care and hybrid care products
  • Telehealth reimbursement and overall health fairness
  • How are sufferers experience about telehealth now?
  • Ultimate views: the long run of telehealth reimbursement

Extra about this episode:

Report reveals ‘vast improvement’ in point out telehealth reimbursement guidelines

COVID-19 may possibly completely alter the telehealth landscape, from reimbursement to utilization

Telehealth reimbursement parity spurs insurer worries of overutilization

CMS will reimburse for eleven new telehealth services in the course of the community overall health crisis

Congressional motion is needed for telehealth not to return to a rural reward, Seema Verma says

Telehealth: A quarter-trillion-dollar publish-COVID-19 truth? (McKinsey)

COVID-19 Shopper Health care Insights: What 2021 may possibly hold (McKinsey)

How COVID-19 has improved the way US shoppers believe about healthcare (McKinsey)